Selected gene–drug relationships
A PGx panel may look at inherited variants linked to medication metabolism, transport, drug targets or certain adverse-reaction risks. The exact genes and medications depend on the selected test.
A clear Canadian guide to medication genetics
What Is PGx Testing and How Does It Work?
PGx testing, short for pharmacogenomic testing, examines selected genetic differences that may influence how your body processes or responds to certain medications. The result can support a more focused discussion with a physician, nurse practitioner or pharmacist, but it does not diagnose a condition, prescribe a drug or guarantee a treatment outcome.
Medication-focused genetic information
Results remain relevant over time
Professional review is encouraged
Direct answer: PGx testing looks for selected genetic variants associated with medication metabolism or response. A report may help a qualified healthcare professional review certain drugs or doses, but the result must still be considered with your diagnosis, symptoms, medication history, other treatments and overall health.
PGx at a glance
The three things to understand first
A useful definition should explain what PGx examines, what the report may contribute and where its limits begin.
A more specific medication review
Results may help organize questions about previous side effects, limited benefit, dose considerations or a medication that is being considered by your care team.
Replace clinical judgement
Genetics does not capture every factor affecting treatment. Current medications, interactions, diagnosis, organ function, age and treatment goals still matter.
Definition and terminology
What does PGx stand for?
PGx is a common abbreviation for pharmacogenomics or pharmacogenomic testing. The field studies relationships between genetic variation and medication exposure, effectiveness or adverse reactions.
Pharmacogenetics is a closely related term. It often refers to one gene or a smaller number of gene–drug relationships, while pharmacogenomics can refer more broadly to multiple genes or genomic information. In everyday healthcare content, the terms are often used interchangeably.
PGx is medication genetics
It is different from ancestry testing, disease-predisposition screening, microbiome testing and drug-allergy testing because its primary question is how selected genetic findings may relate to medication use.
Understanding your report
Common terms found in a PGx result
Reports can look technical, but most of the terminology follows a predictable path from the genetic finding to a possible medication consideration.
Variant
A difference at a particular location in DNA. Only variants included in the selected panel can appear in the result.
Genotype
The genetic result detected for a gene or marker. Some genes may also use star-allele or diplotype notation.
Phenotype
An interpretation of predicted gene function, such as poor, intermediate, normal, rapid or ultrarapid metabolism where those categories apply.
Gene–drug guidance
Medication-specific context based on the result, available evidence and the interpretation system used by the report.
Examples, not a complete panel
What kinds of genes can PGx testing examine?
Test coverage differs. A gene appearing on a panel does not mean that every possible medication has an equally strong or actionable relationship with it.
| Gene or category | What it may affect | What the result does not prove |
|---|---|---|
| CYP2D6 | The metabolism of selected antidepressants, pain medications, cardiovascular drugs and other medicines. | It does not determine the safety or effectiveness of every medication processed through this pathway. |
| CYP2C19 | The metabolism of selected mental-health, antiplatelet, gastrointestinal and other medications. | It does not replace the reason for treatment, interaction checks or clinical monitoring. |
| Transport genes | How selected medications move into, through or out of cells and tissues. | A transport finding does not describe every factor controlling medication exposure. |
| Immune-risk markers | The likelihood of certain serious reactions for selected gene–medication combinations. | These markers do not prove or rule out every drug allergy or adverse reaction. |
| Drug-target genes | The structure or function of a target that selected medications are designed to affect. | A target-related result does not guarantee clinical benefit or freedom from side effects. |
How testing works
From an at-home sample to a medication discussion
The exact sample type, laboratory method, gene panel and processing time depend on the test. Confirm those details before ordering.
Choose a relevant test
Confirm that the panel includes the genes and medications connected to your real question rather than relying only on the total number of items listed.
Collect the sample
Follow the kit instructions, consent process, packaging requirements and return directions carefully to reduce avoidable delays.
Receive the report
Begin with the medication-specific sections, phenotype explanations, evidence notes and report limitations.
Review the findings
Bring the report and a complete medication list to the clinician or pharmacist responsible for the relevant treatment decision.
Canadian access and follow-up
How PGx testing fits into healthcare in Canada
At-home collection can make testing accessible outside major medical centres, but the practical experience can still vary by province, territory and community.
- Delivery and sample-return time may be longer in remote locations.
- Public and private insurance coverage should not be assumed.
- Access to a physician, nurse practitioner or pharmacist for review can differ by community.
- A report may need updated interpretation when evidence or medication guidance changes.
- Online ordering does not create a prescribing or healthcare relationship by itself.
Vancouver
Calgary
Edmonton
Regina
Winnipeg
Toronto
Ottawa
Montréal
Halifax
Remote communities
Realistic expectations
What PGx testing can and cannot tell you
Clear limitations make the result more useful because they prevent a decision-support report from being mistaken for a diagnosis or prescription.
Information the report may provide
- Predicted function for selected medication-related genes.
- Medication sections that deserve closer professional review.
- Questions about metabolism, exposure or selected reaction risks.
- Genetic information that may remain relevant for future medication discussions.
- A structured report that can support medication reconciliation.
Answers the report does not provide
- One perfect medication for every person or condition.
- A diagnosis or confirmation that medication is required.
- The correct dose without considering clinical information.
- Prevention of every adverse effect or treatment failure.
- A complete drug-interaction, allergy or medication-safety review.
Do not change medication independently
Do not start, stop, switch or change the dose of a medication based only on a PGx report. Medication decisions should remain with the qualified professional responsible for your care.
Preparing for professional review
What to bring to a PGx report discussion
Genetics becomes more useful when it is connected to the medications, responses and treatment questions that matter now.
- Your complete prescription and non-prescription medication list.
- Current doses and how long each medication has been used.
- Previous medications that caused side effects or limited benefit.
- Known allergies, diagnoses and relevant laboratory information.
- The specific gene–drug sections you want reviewed.
- The full report rather than a screenshot of one colour category.
Evidence and responsible interpretation
Why medication-specific evidence matters
PGx is not one universal rule applied to every medication. The strength and actionability of a finding depend on the gene, variant, medication, clinical guideline, drug label and the patient's full care context.
Guidance is drug-specific
A useful recommendation should identify the medication and the gene–drug relationship supporting the interpretation.
Evidence levels differ
Not every marker on a large commercial panel has the same level of clinical evidence or prescribing relevance.
Interpretation can evolve
Your inherited genotype is generally stable, but guidelines, labels, allele definitions and report software may change.
What is PGx FAQ
Direct answers to common PGx questions
These answers explain the fundamentals without presenting genetic testing as a replacement for individualized medication care.
What is PGx testing?
PGx testing is pharmacogenomic testing. It examines selected genetic variants associated with how certain medications may be metabolized or responded to. The result may support a medication discussion, but it does not diagnose a condition, write a prescription or guarantee that a medication will work.
Is PGx the same as pharmacogenetic testing?
The terms are closely related and are often used interchangeably. Pharmacogenetics commonly refers to one or a smaller number of gene–drug relationships, while pharmacogenomics can describe a broader analysis involving multiple genes or genomic information.
Can PGx testing find the best medication?
It cannot guarantee one best medication. A report may identify selected drugs that deserve closer review because of a supported gene–drug relationship. Diagnosis, symptoms, interactions, previous response, other health conditions and treatment goals still influence the final decision.
Does PGx testing replace drug-allergy testing?
No. Pharmacogenomic testing and drug-allergy testing answer different questions. A PGx result generally does not prove or rule out an immune-mediated allergy. Report known or suspected medication allergies to the healthcare professional reviewing your treatment.
Do PGx results change over time?
Your inherited genetic variants generally remain stable. Interpretation may change as scientific evidence, drug labels, clinical guidelines and report systems develop. An older report may therefore need current professional interpretation when a new medication is considered.
Is PGx testing covered in Canada?
Coverage is not universal. Provincial programs, private insurance, employer benefits and health spending accounts may apply different rules. Confirm eligibility, documentation requirements and the total cost before ordering rather than assuming reimbursement.
Do I need a doctor to order a PGx test?
Ordering requirements depend on the provider, test and intended use. Some services offer online ordering and at-home collection. Regardless of how the test is ordered, medication-related findings should be reviewed with a qualified prescriber or pharmacist.
Is PGx testing useful if a medication already caused problems?
Previous medication experience can give the report useful context. Testing may help a professional review whether a supported gene–drug relationship is relevant, but it cannot prove that genetics caused the earlier response or explain every side effect.
Continue your research
Open the page that matches your next PGx question
These internal resources separate test basics, report use, medication review, evidence, coverage and professional workflows.
Move from definition to a real decision
Compare the panel, report and support before ordering
Start with the medication question you want to explore. Then confirm which genes and medications are included, how the sample is collected, what the report looks like and who can help you review the result.
Medical disclaimer: This page provides general educational information and is not medical advice, diagnosis, treatment or a prescription. PGx results should be reviewed with a qualified healthcare professional who can consider your diagnosis, symptoms, current and previous medications, interactions, allergies and overall health.